Tag: genomics
-
Hispanic Neuro Disease Landscape Mapped in New Study
A new project examines brain pathologies leading to development of Alzheimer’s disease in Americans of Hispanic descent, a group largely ignored in neuroscience.
-
Controlled Brain Tumor Gene Therapy Shown Safe
A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer.
-
Engineered Bacteria Hydrogels Designed for Gut Repair
Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces.
-
FDA Investigating Data Manipulation in Gene Therapy Approval
The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease.
-
Company Forms to Treat Vaginal Microbial Disorders
A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities.
-
Trial Shows Immunotherapies Extend Life with Melanoma
First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers.
-
Crispr Enhanced for RNA Editing
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases.
-
Immunotherapy Biotech Gains $325M in Venture Funds
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round.
-
Start-Up Creating Blood Tests, Apps for Mental Disorders
A new enterprise based on psychiatric and molecular research at Indiana University is developing precision-medicine diagnostics for pain and mental disease.
-
Stem Cell Start-Up Raises $250M in Venture Funds
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing.